·7 min read

How Neura Is Personalizing Brain Health Through Genomics

Neura uses DNA-driven nutrigenomics to formulate custom cognitive supplements — moving brain health from guesswork to precision science. Here's how they're doing it.

Neuranutrigenomicsbrain healthprecision medicinebiotechneura-bio

The Supplement Aisle Is Lying to You

Walk into any pharmacy or health food store and you'll see the same spectacle: walls of shrink-wrapped bottles making identical promises. "Boost focus." "Support memory." "Enhance clarity." The ingredients lists are nearly interchangeable. The dosages are pulled from population averages. And the only personalization on offer is a label that says "Men's Formula" or "50+."

This is a $50 billion industry running on a deeply flawed assumption — that one formula can meaningfully serve all brains. But brains are not the same. The gene variants you carry fundamentally determine how you metabolize B-vitamins, break down neurotransmitters, manage neuroinflammation, and build new neural connections. What produces clarity in one person may produce anxiety in another. What supports memory for one genotype may be entirely inert for the next.

The science has known this for years. The industry has mostly ignored it.

Neura is changing that.

The core insight: Over 80 genetic variants directly influence cognitive function — from how your brain makes dopamine to how efficiently it processes folate. Neura is the first consumer platform to use all of them together to build a genuinely unique supplement formulation for each person.

What Neura Does: Test, Formulate, Track, Refine

Neura is a precision brain health company built on the science of nutrigenomics — the study of how your genes interact with the nutrients you consume. The platform works in four stages that form a continuous loop:

  1. Genomic testing: A simple at-home saliva kit analyzes over 80 genetic variants tied to cognitive function. This includes COMT and MAO variants that govern neurotransmitter breakdown speed, MTHFR polymorphisms that affect methylation and B-vitamin utilization, APOE status which signals neuroinflammation risk, and BDNF variants tied to neuroplasticity and memory consolidation.
  2. Custom formulation: From your genomic profile, Neura's system — built on a database of peer-reviewed nutrigenomics research — determines not just which ingredients you need, but what form and dose. Someone with MTHFR C677T, for example, can't properly convert folic acid into its active form. Their formula uses methylfolate instead. This is not a personalization sticker on a mass-produced pill. It's a genuinely unique stack, manufactured in an FDA-registered facility.
  3. Cognitive tracking: Neura pairs your supplements with a science-backed tracking protocol that measures working memory, processing speed, and mood state over time. You're not just taking pills and hoping — you're gathering data on your own performance.
  4. Refinement: As your cognitive data accumulates, your formulation can be adjusted. The goal is a feedback loop between your genomic baseline, your supplement protocol, and your actual measured outcomes. This is what personalized medicine looks like applied to consumer wellness.
The Neura Precision Loop 01 Saliva Test 80+ gene variants 02 Custom Formula Form, dose, stack 03 Track Cognition Memory, speed, mood 04 Refine Formula Data-driven updates Continuous feedback loop

Who Neura Is Built For

Neura isn't for the casual supplement buyer tossing a generic fish oil bottle into their cart. It's built for a growing cohort of cognitively ambitious people who want to take brain health seriously — and who are frustrated that "serious" options haven't previously existed in this space.

  • High-performance professionals — founders, executives, and knowledge workers who treat their cognitive output as a professional asset and want the same rigor in their health stack that they apply to their work.
  • Biohackers and quantified-selfers — people already tracking sleep, HRV, and glucose who are looking for the missing layer: genetics-informed supplementation with measurable outcomes.
  • People with family history concerns — individuals aware of APOE risk factors or family history of cognitive decline who want proactive, science-grounded strategies rather than waiting for symptoms.
  • Frustrated supplement consumers — people who've tried standard nootropics, felt nothing meaningful, and are ready to understand why and get something that actually fits their biology.

The common thread is someone who's done the research, knows that genetics matters, and is ready to stop experimenting blindly.

Why Neura Stands Apart

The personalized supplement space has attracted attention in recent years — companies like Care/of and Ritual offer questionnaire-based recommendations. But questionnaire personalization has a ceiling. Self-reported habits don't reveal your COMT val158met genotype. A survey can't tell you whether your MTHFR status means folic acid is building up in your bloodstream rather than converting to the methylfolate your brain needs.

Neura's differentiation is real biological depth:

Neura vs. Standard Personalized Supplements FEATURE TYPICAL BRANDS NEURA Personalization basis Questionnaire 80+ genetic variants Ingredient forms Generic (e.g. folic acid) Genotype-matched Outcome tracking None Cognitive protocol built-in Formula updates Static Data-driven iteration Scientific advisory Marketing advisors UCSF neurogenomics team

Neura's advisory board includes neurogenomics researchers from UCSF and supplement formulators with decades of evidence-based experience. This is the credibility layer that separates a real precision health company from a branding exercise.

The Market Opportunity: Where Genomics Meets Wellness

The timing for Neura couldn't be better. Three forces are converging:

1. Consumer genomics is mainstream. More than 30 million people have taken at-home DNA tests in the US alone. The resistance to genetic testing has collapsed. Consumers are comfortable with it — and they're hungry for actionable insights beyond ancestry maps.

2. The nootropics market is exploding. Global demand for cognitive enhancement supplements is growing rapidly, but the category is plagued by a credibility crisis. Consumers are becoming sophisticated enough to be skeptical of generic claims, creating a vacuum at the top of the market for science-first brands.

3. Precision medicine is moving to consumer health. What started in oncology and rare disease is becoming a consumer expectation. People who've seen precision approaches transform cancer treatment are asking why their vitamins are still one-size-fits-all.

$50B
Global supplement market
$5.6B
Nootropics segment, growing 12% YoY
30M+
US consumer DNA test takers
80+
Gene variants analyzed per customer

Neura is positioned at the intersection of all three trends — a company that could only exist right now, when genomic testing is cheap, when nutrigenomics research has matured, and when consumers are ready to demand more from their health spending.

"The supplement industry has had decades to solve personalization. It chose marketing instead. We chose science."

Built on AI, Grounded in Science

Neura was conceived and launched using Artha, an AI platform that builds fully operational companies from a single prompt. What would have taken months of agency work, co-founder searching, and fragmented tooling — brand identity, website, product architecture, go-to-market positioning — was assembled and launched through Artha's AI-native infrastructure.

The result is a company that moves with the speed a deep-science venture demands. Neura's platform can ship and iterate on its genomic formulation logic, its cognitive tracking UX, and its customer education content without the overhead that typically slows health-tech startups to a crawl. This is what it looks like when precision medicine meets precision building.

What Comes Next for Neura

The initial product — genomic test, custom formulation, cognitive tracking — is the foundation. But the roadmap extends significantly further:

  • Longitudinal genomic data: As Neura accumulates cognitive performance data across its user base, the platform gains the ability to refine its nutrigenomic models using real-world outcomes — not just published studies. This creates a compounding data moat.
  • Expanded biomarker integration: Pairing genomic data with bloodwork and wearable inputs (sleep quality, HRV, cortisol patterns) to create a fuller biological picture and even more targeted formulations.
  • Enterprise and clinical partnerships: Bringing precision cognitive health into employee wellness programs and preventive neurology practices, where APOE-aware supplementation protocols have clear clinical value.
  • Broader neurological focus: Extending the platform beyond general cognitive performance into specific populations — early Alzheimer's risk management, ADHD support, post-COVID cognitive rehabilitation.

The vision is a platform where every person's brain health strategy is as unique as their genome — continuously refined, continuously measured, never generic.

Build Your Precision Health Company on Artha

Neura is what happens when a genuinely important scientific insight meets a platform capable of turning it into a real company at speed. The nutrigenomics science existed. The consumer readiness existed. What Neura needed was the infrastructure to build, launch, and grow — and Artha provided it.

If you have a company idea — in health, biotech, consumer wellness, or any other space — that deserves to exist, Artha can help you build it. Not a prototype. Not a pitch deck. A real, operating company, built by AI from a single prompt.

Start building on Artha →

Build your company with AI

Describe your idea in one prompt. Artha builds your website, finds customers, and runs marketing.

Try Artha free →